| Literature DB >> 34322211 |
Mehdi Abrishami1, Arash Golestaneh1, Laleh Maleki2, Hasan Momeni1, Mazyar Manshaei3.
Abstract
BACKGROUND: Infraorbital nerve injury often occurs due to zygomatic complex fracture. There is no standard protocol to restore the sensory and motor function of the nerve after injury. Some medications are used to improve nerve function. This histopathological animal study aimed to assess the neurotrophic efficacy of exenatide, ozone, and methyl prednisolone for injured infraorbital nerve.Entities:
Keywords: Exenatide; infraorbital nerve; methylprednisolone; nerve injury; ozone
Year: 2021 PMID: 34322211 PMCID: PMC8314971
Source DB: PubMed Journal: Dent Res J (Isfahan) ISSN: 1735-3327
Figure 1Normal nerve cross-section in the control group with no damage to the nerve (H and E, ×40).
Figure 6Confirming nerve degeneration by detection of macrophages at the site using CD68 marker (CD68, ×400).
Frequency distribution of different histological parameters in the five groups
| Variable | Group (%) | ||||||
|---|---|---|---|---|---|---|---|
| Category | Control | Saline (dose) | Methyl prednisolone (dose) | Exenatide (dose) | Ozone (dose) | ||
| Peripheral inflammation | Absence | 14 (100) | 2 (14.3) | 10 (83.3) | 11 (78.6) | 2 (14.3) | 0.001 |
| Presence | 0 (0) | 12 (85.7) | 2 (16.7) | 3 (21.4) | 12 (86.7) | ||
| Degeneration | No degeneration | 14 (100) | 0 (0) | 0 (0) | 3 (21.4) | 0 (0) | 0.001 |
| Mild degeneration | 0 (0) | 5 (37.5) | 10 (83.3) | 10 (71.4) | 13 (92.2) | ||
| Severe degeneration | 0 (0) | 9 (64.3) | 2 (16.7) | 1 (7.1) | 1 (7.1) | ||
| Intraneural inflammatory infiltration | Absence | 14 (100) | 14 (100) | 12 (100) | 14 (100) | 3 (21.4) | 0.001 |
| Presence | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 11 (78.6) | ||
| Muscle injury | Absence | 14 (100) | 13 (92.2) | 12 (100) | 13 (92.2) | 2 (14.3) | 0.001 |
| Presence | 0 (0) | 1 (7.1) | 0 (0) | 1 (7.1) | 12 (85.7) | ||
| Perineural fibrosis | Absence | 14 (100) | 14 (100) | 12 (100) | 14 (100) | 13 (92.9) | 0.001 |
| Presence | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (7.1) | ||
| Granulation tissue around the nerve | Absence | 14 (100) | 7 (50) | 12 (100) | 14 (100) | 5 (35.7) | 0.001 |
| Presence | 0 (0) | 7 (50) | 0 (0) | 0 (0) | 9 (64.3) | ||
| Perineural vascularization | Absence | 14 (100) | 7 (50) | 12 (100) | 14 (100) | 5 (35.7) | 0.001 |
| Presence | 0 (0) | 7 (50) | 0 (0) | 0 (0) | 9 (64.3) | ||
| Perineural inflammatory infiltration | Absence | 14 (100) | 7 (50) | 12 (100) | 14 (100) | 5 (35.7) | 0.001 |
| Presence | 0 (0) | 7 (50) | 0 (0) | 0 (0) | 9 (64.3) | ||
Pairwise comparisons of the groups regarding the studied variables
| Variable Study groups | Histopathological findings | |||||||
|---|---|---|---|---|---|---|---|---|
| Peripheral tissue inflammation | Degeneration | Intraneural inflammatory infiltration | Muscle injury | Perineural fibrosis | Perineural granulation tissue | Perineural vascular proliferation | Perineural infiltration of inflammatory cells | |
| Control | 0 (0.0)a,d | 0 (0.0)a,b,c,d | 0 (0.0)d | 0 (0.0)d | 0 (0.0) | 0 (0.0)a,d | 0 (0.0)a,d | 0 (0.0)a,d |
| Saline | 12 (85.7)e,f | 14 (100) | 0 (0.0)g | 1 (7.1)g | 0 (0.0) | 7 (50)e,f | 7 (50)e,f | 7 (50)e,f |
| Methyl prednisolone | 2 (16.7)i | 12 (100) | 0 (0.0)i | 0 (0.0)i | 0 (0.0) | 0 (0.0)i | 0 (0.0)i | 0 (0.0)i |
| Exenatide | 3 (21.4)j | 11 (78.6) | 0 (0.0)j | 1 (7.1)j | 0 (0.0) | 0 (0.0)j | 0 (0.0)j | 0 (0.0)j |
| Ozone | 12 (85.7) | 14 (100) | 11 (78.6) | 12 (85.7) | 1 (7.1) | 9 (64.3) | 9 (64.3) | 9 (64.3) |
a(P<0.05) control versus normal saline; b(P<0.05) control versus methylprednisolone is; c(P<0.05) control versus exenatide; d(P<0.05) control versus ozone; e(P<0.05) normal saline versus methylprednisolone; f(P<0.05) normal saline versus exenatide; g(P<0.05) normal saline versus ozone; h(P<0.05) methylprednisolone versus exenatide; i(P<0.05) methylprednisolone versus ozone; j(P<0.05) exenatide versus ozone
Figure 7Overall improvement of the sensory function of infraorbital nerve after injury in the five groups.